Say hello to #OnKure’s newest Research Scientist, Sayali Upasham Lewis. Welcome to the #OnKure team!
OnKure Therapeutics’ Post
More Relevant Posts
-
ExstoBio is excited to once again partner with CGsquared - Carolina Graduate Consulting Group for another exciting project! (CG)^2 is a consulting group out of University of North Carolina at Chapel Hill and Duke University that focuses in the life science, medtech, and healthcare sectors. Teams are composed of Ph.D. candidates and postdoctoral fellows with higher order training in critical thinking and data analysis, combining business principles with niche scientific knowledge to provide actionable recommendations to their clients. For ExstoBio, (CG)^2 will conduct interviews and explore the relationship between #physicians and #patients with #Autism Spectrum Disorder. Their research and work will dive into: (i) physician's concerns with medical cannabis for the treatment of Autism Spectrum Disorder; (ii) Autistic patients' needs for incorporating non-psychoactive cannabis into their care plan; and (iii) how physicians would like to be supported while treating their patients with cannabinoid therapies. Our partnership will culminate in the identification of strategic partners, and provide greater insights into how to best serve doctors and their patients. Let us know if you are a doctor, parent, or patient and you want to learn more! #StopGuessingStartTreating #PatientCenteredPhysicianLed
To view or add a comment, sign in
-
-
The NeuraLight team had a fantastic time HLTH 2023 in Vegas, taking part in important discussions about the impact #digitalhealth technology can have, and is already having, on patient care and outcomes. Here's some highlights from the week: 💡 The prevalence of #neurodegenerative diseases like #parkinsons and #alzheimers is rising, and what we need most are advances in #biomarkers, #digitalbiomarkers included. Hearing representatives from WVU Rockefeller Neuroscience Institute, Neurotrack, The Michael J. Fox Foundation for Parkinson's Research, Eli Lilly and Company, and Magnify Ventures speak on this topic on Sunday was powerful 💡 Cross-industry collaboration is needed to propel the use of digital technologies in clinical drug discovery and patient care forward. We're exited to be partnering with the team at Digital Medicine Society (DiMe) to help bring the right stakeholders together to move the needle 💡 Biopharma companies like Roche, Bayer, Johnson & Johnson and others are proponents of digital technologies, and have an important role to play in advancing research, development, and adoption of such tools 💡 Interest and excitement about #oculometrics is growing! If you didn't get to see us or check out our demo at HLTH, please reach out to our team to set up time for an introduction, or a deeper dive on our science and tech
To view or add a comment, sign in
-
Empowering Communities Through Clinical Research At 3SYNC Research, our community pod model isn't just an image; it's a testament to our mission. We offer comprehensive tools, training, and guidance, revolutionizing the way clinical research integrates into communities. Our model solves the crucial need for more Principal Investigators by mentoring new talent into the field. This strategy, depicted in our post image, underscores our commitment to expanding research access and fostering collaborations. With 3SYNC, every stakeholder finds a trusted partner and a clear path forward in clinical research. 1-800-733-7962 www.3sync.com #CommunityHealth #ClinicalResearch #3SYNCResearch
To view or add a comment, sign in
-
-
Last chance to register! 👉 https://buff.ly/3XmDSEj Join us at 2pm BST for a discussion around moving compounds to IND using predictive retina models💡 #Newcells #VisionResearch #Retina #PredictiveModels
Our next webinar takes place tomorrow! ⏰ 📌 Moving compounds to IND using predictive retina models Our expert panelists will share their insights from Regulatory, Technology, and Scientific Perspectives. They will also delve into strategies for streamlining the clinical development pipeline, with a special focus on retina-related compounds. 🔬Speakers: Dr Lauren E. Black - Distinguished Scientist/Consultant, working mainly at the first in human (FIH) stage - in high-risk diseases using novel products at Charles River Laboratories Dr Roxana Redis - Associate Science Director, leading the development of the ASO hit to lead platform within Early Discovery at Charles River Laboratories Dr Valeria Chichagova, PhD - Director of Technology, Newcells Biotech 📅 June 19th - 2:00 PM BST Find out more and register here: https://buff.ly/3XmDSEj #Newcells #VisionResearch #Retina #PredictiveModels
To view or add a comment, sign in
-
-
If you are attending the #AGBT #PrecisionHealth meeting today, don’t miss out on the opportunity to connect with Dr. Daniel Cook during his poster presentation from 4:35 p.m. to 6:35 p.m. Learn more about our next-generation technology for #surgicalplanning. #PrecisionOncology #PrecisionMedicine
To view or add a comment, sign in
-
-
Invent: Life Sciences is a podcast exploring the impact of biology and technology on the life sciences sector. This week, on the topic Sex and Gender in Medical Research, podcast’s host Stuart Lowe and experts Diana Torgersen, Shirin Heidari and Deana Mohr-Haralampieva are discussing the implications of lack of sex and gender in research and potential solutions to marginalized groups. Curious to know more? Tune in: https://lnkd.in/dzwZH5jJ #gender #healthresearch #gendermedicine #SAGERguidelines GENDRO.ORG, Geneva Graduate Institute, European Association of Science Editors (EASE)
🎙️Episode 6 of Invent Life Sciences is out now!🎙️ This week: Sex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups? Throughout almost all of medical history, it was assumed that the average white male response to drug trials could be extrapolated to all potential recipients. But when we look at the poorer health outcomes for women and minorities, could the underlying assumptions in medical research be a contributing factor? If so, what is being done to solve them? To find out, join us on Invent: Life Sciences, with your host Stuart Lowe and this weeks' special guests: ✔️Diana Torgersen, Executive Director for External Innovation & Emerging Science at Organon ✔️Shirin Heidari, Founding President of GENDRO ✔️Deana Mohr-Haralampieva, CEO of MUVON Therapeutics Listen now: https://lnkd.in/ezJ_xv2Y
To view or add a comment, sign in
-
Today we welcome Harold Lehmann and Ken Wilkins at the #N3CommunityForum to present "Assess Your Design/Analysis in light of Best Practices: a Guide to N3C Chapter." Register for the #webinar at http://bit.ly/N3CRegister #N3C #informatics #Data
Join us on Monday for our next #N3CommunityForum at 5 pm ET / 2 pm PT. Hear from Harold Lehmann and Ken Wilkins on "Assess Your Design/Analysis in light of Best Practices: a Guide to N3C Chapter." Register at http://bit.ly/N3CRegister #Data #analysis #webinar #N3C National Center for Advancing Translational Sciences (NCATS)
To view or add a comment, sign in
-
-
Chief Medical Officer & Director, Office of Translational Medicine, National Center for Advancing Translational Sciences (NCATS), NIH - opinions expressed are entirely my own
🗣 📢 AVAILABLE NOW!!!! Special thematic issue of the Journal of Clinical and Translational Science - "Advancing Translational Science Through Real-World Data and Real-World Evidence" This issue of JCTS represents a *massive* team effort on the part of the journal, the guest editors, the authors, and the reviewers. Huge thanks to everyone who made it possible, and a special shoutout to my friends and colleagues at National Center for Advancing Translational Sciences (NCATS) and FDA who let me be a small part of the team! #RWD #RWE https://lnkd.in/eZPKFGUV
To view or add a comment, sign in
-
Today, we honor the dedication, passion, and hard work that drives progress and innovation. To everyone who contributes tirelessly in their respective fields: Thank you. May this Labor Day remind us of the collective spirit that pushes boundaries and creates a brighter tomorrow. Here's to determination, commitment, and achievements. Enjoy the well-deserved break! - - - - - #NeuroBehavioralClinicalResearch #NBRClinic #ClinicalResearchTrials #BehavioralResearch #ClinicalResearch #LaborDay #LaborDay2023 #HappyLaborDay
To view or add a comment, sign in
-
-
Are you in Boston for this week's Spatial Biology for Drug Development Summit? Don't miss our presentation today at 5 PM titled "Interpreting Large & Complex Spatial Biology Datasets – From Discovery to Clinical Research," by Mark Landers, VP of Precision Medicine at Akoya. You'll learn about: ✔️ Interpreting complex spatial biology data from a large number of markers ✔️ The significance of integrating data analysis strategies with the clinical context ✔️ Assessing prognostic or predictive value #spatialbiology #drugdevelopment #biomarker #spatialproteomics #singlecell
Spatial Biology for Drug Development
spatialbiology-drugdevelopment.com
To view or add a comment, sign in